Literature DB >> 20933139

Lyme borreliosis in dogs and cats: background, diagnosis, treatment and prevention of infections with Borrelia burgdorferi sensu stricto.

Inke Krupka1, Reinhard K Straubinger.   

Abstract

Lyme borreliosis (LB), synonymous with the often-used term Lyme disease, is an infectious disease caused by the spirochetal bacterium Borrelia burgdorferi. LB is the most frequent vector-borne disease in humans in the Northern Hemisphere. In animals, clinically apparent disease is found primarily in dogs. Severe polyarthritis, fever and lameness in dogs are reported from the main endemic areas of North America: the New England States, and eastern parts of the United States; several cases of LB are also seen in California and the Midwest. Because of the difficulties in finding sufficient indicative clinical signs, additional information (detailed case history, laboratory testing for antibodies) is especially important to make the clinical diagnosis of Lyme borreliosis. This article reviews the etiology, diagnosis, therapy, and prevention of LB.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20933139     DOI: 10.1016/j.cvsm.2010.07.011

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  25 in total

1.  Seroprevalence of some vector-borne infections of dogs in Hungary.

Authors:  Robert Farkas; Mónika Gyurkovszky; Zoltán Lukács; Balázs Aladics; Norbert Solymosi
Journal:  Vector Borne Zoonotic Dis       Date:  2014-04-01       Impact factor: 2.133

2.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

3.  The increasing risk of Lyme disease in Canada.

Authors:  Catherine Bouchard; Erin Leonard; Jules Konan Koffi; Yann Pelcat; Andrew Peregrine; Neil Chilton; Kateryn Rochon; Tim Lysyk; L Robbin Lindsay; Nicholas Hume Ogden
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

Review 4.  Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes.

Authors:  Justin D Radolf; Melissa J Caimano; Brian Stevenson; Linden T Hu
Journal:  Nat Rev Microbiol       Date:  2012-01-09       Impact factor: 60.633

Review 5.  Ticks and their epidemiological role in Slovakia: from the past till present.

Authors:  Michal Stanko; Markéta Derdáková; Eva Špitalská; Mária Kazimírová
Journal:  Biologia (Bratisl)       Date:  2021-09-17       Impact factor: 1.653

6.  Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design.

Authors:  D V L Rhodes; C G Earnhart; T N Mather; P F M Meeus; R T Marconi
Journal:  Vet J       Date:  2013-08-17       Impact factor: 2.688

7.  Protein-losing nephropathy associated with Borrelia burgdorferi seropositivity in a soft-coated wheaten terrier: response to therapy.

Authors:  Barbara S Horney; Vladimir Stojanovic
Journal:  Can Vet J       Date:  2013-04       Impact factor: 1.008

Review 8.  The immunopathology of canine vector-borne diseases.

Authors:  Michael J Day
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

9.  Canine vector-borne infections in Mauritius.

Authors:  Gary Kwok Cheong Lee; Jean Alain Ean Ignace; Ian Duncan Robertson; Peter John Irwin
Journal:  Parasit Vectors       Date:  2015-03-23       Impact factor: 3.876

10.  Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.

Authors:  A C Camire; A L Hatke; V L King; J Millership; D M Ritter; N Sobell; A Weber; R T Marconi
Journal:  Vet J       Date:  2021-04-14       Impact factor: 2.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.